These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 16445120

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. State-of-the-art genomics approaches in toxicology.
    Van Hummelen P, Sasaki J.
    Mutat Res; 2010 Dec; 705(3):165-71. PubMed ID: 20466069
    [Abstract] [Full Text] [Related]

  • 5. Strategic applications of toxicogenomics in early drug discovery.
    Ryan TP, Stevens JL, Thomas CE.
    Curr Opin Pharmacol; 2008 Oct; 8(5):654-60. PubMed ID: 18760379
    [Abstract] [Full Text] [Related]

  • 6. The Japanese toxicogenomics project: application of toxicogenomics.
    Uehara T, Ono A, Maruyama T, Kato I, Yamada H, Ohno Y, Urushidani T.
    Mol Nutr Food Res; 2010 Feb; 54(2):218-27. PubMed ID: 20041446
    [Abstract] [Full Text] [Related]

  • 7. Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit?
    Lühe A, Suter L, Ruepp S, Singer T, Weiser T, Albertini S.
    Mutat Res; 2005 Aug 04; 575(1-2):102-15. PubMed ID: 15924886
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The use of toxicogenomic data in risk assessment: a regulatory perspective.
    Chan VS, Theilade MD.
    Clin Toxicol (Phila); 2005 Aug 04; 43(2):121-6. PubMed ID: 15822767
    [Abstract] [Full Text] [Related]

  • 13. Identification of potential genomic biomarkers of hepatotoxicity caused by reactive metabolites of N-methylformamide: Application of stable isotope labeled compounds in toxicogenomic studies.
    Mutlib A, Jiang P, Atherton J, Obert L, Kostrubsky S, Madore S, Nelson S.
    Chem Res Toxicol; 2006 Oct 04; 19(10):1270-83. PubMed ID: 17040096
    [Abstract] [Full Text] [Related]

  • 14. A retrospective analysis of toxicogenomics in the safety assessment of drug candidates.
    Foster WR, Chen SJ, He A, Truong A, Bhaskaran V, Nelson DM, Dambach DM, Lehman-McKeeman LD, Car BD.
    Toxicol Pathol; 2007 Aug 04; 35(5):621-35. PubMed ID: 17654404
    [Abstract] [Full Text] [Related]

  • 15. Genomic and proteomic profiling for biomarkers and signature profiles of toxicity.
    Merrick BA, Bruno ME.
    Curr Opin Mol Ther; 2004 Dec 04; 6(6):600-7. PubMed ID: 15663324
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Application of genomics in preclinical drug safety evaluation.
    Lord PG, Nie A, McMillian M.
    Basic Clin Pharmacol Toxicol; 2006 Jun 04; 98(6):537-46. PubMed ID: 16700814
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Role of toxicogenomics in the development of safe, efficacious and novel anti-microbial therapies.
    Sabir JS, Abu-Zinadah OA, Bora RS, Ahmed MM, Saini KS.
    Infect Disord Drug Targets; 2013 Jun 04; 13(3):206-14. PubMed ID: 24087896
    [Abstract] [Full Text] [Related]

  • 20. Toxicogenomics for the prediction of toxicity related to herbs from traditional Chinese medicine.
    Youns M, Hoheisel JD, Efferth T.
    Planta Med; 2010 Dec 04; 76(17):2019-25. PubMed ID: 20957595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.